2024-Oct On behalf Oncosyne and collaborators Dr. Sebastian Meltzer (Ahus) and Dr. Teijo Pellinen (FIMM), Jarle Bruun, Peter W, Eide and Christer A. Andreassen presented a poster entitled μCAN – drug discovery, development and diagnostics using clinical grade drug screening and predictive phenotyping of patient-derived tumoroids at the ELRIG UK Drug Discovery 2024 conference in London.
